Cancer vaccine - Immunotech Laboratories

Drug Profile

Cancer vaccine - Immunotech Laboratories

Alternative Names: IPF-based cancer vaccine - Immunotech Laboratories; Irreversible pepsin fraction-based cancer vaccine - Immunnotech Laboratories

Latest Information Update: 11 Feb 2013

Price : $50

At a glance

  • Originator Immunotech Laboratories
  • Class Cancer vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Clinical Phase Unknown Cancer

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 01 Jan 2013 Clinical trials in Cancer in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top